Scott Braithwaite, MD, MSc
NYU Langone Health - Tenured Professor of Medicine
NYU Langone Health - Director, Division of Comparative Effectiveness and Decision Science
MD, Medicine, SUNY at Stony Brook School of Medicine
MSc, Clinical Research, University of Pittsburgh
BS, Physics, Massachusetts Institute of Technology
Research Interests
Cost-effectiveness, Decision science
R. Scott Braithwaite is a Tenured Professor, Chief of the Section on Value Effectiveness (SOLVE) and Director of the Division of Comparative Effectiveness at New York University School of Medicine-Department of Population Health.  Dr. Braithwaite earned his MD from the State University of New York at Stonybrook and his MSc in Clinical Research from the University of Pittsburgh. Dr. Braithwaite also completed a fellowship in Clinical Decision Making at Tufts University and is a recipient of a prestigious Robert Wood Johnson Foundation Faculty Scholar award. He is an accomplished investigator in the field of decision science, quality and cost-effectiveness with an outstanding record of funding from the NIH and other extramural sources. As chief of SOLVE, he is dedicated to advancing a program of rigorous, policy-relevant research to optimize quality and value in healthcare, incorporating methods of decision science, comparative effectiveness and cost effectiveness. In addition to his focus on improving care for chronic illness domestically, he also continues his important international work on HIV treatment strategies in developing countries.
Principal Investigator, Could Long-Acting Medications Facilitate “Ending AIDS by 2030” in Southern Africa? An Allocative Efficiency Analysis. Active
Principal Investigator, From 90-90-90 to 95-95-95 and Beyond: Optimizing and Targeting Combination HIV Prevention for Zimbabwe and Kwazulu Natal. Active
Principal Investigator, Reducing Morbidity and Mortality from Overdose, HIV, and Hepatitis C in Opioid-Using Persons. Active
Principal Investigator, 4/6 COMPAAAS U01: Operations Research Study. Completed
Principal Investigator, Benefits and Harms of Lung Cancer Screening in HIV Infection. Completed
Principal Investigator, Implementation Science to Optimize HIV Prevention in East Africa PEPFAR Programs. Completed
Principal Investigator, Mentored Career Development in Comparative Effectiveness Research. Completed
Principal Investigator, Operations Research Collaboration for Alcohol Abuse and AIDS: ORCAAA. Completed
Principal Investigator, Should Screening and Treatment Strategies for Unhealthy Alcohol Misuse in HIV-infected Persons Vary with Smoking, Depression and Substance Abuse?. Completed


Feelemyer JP, Richard E, Khan MR, Scheidell JD, Caniglia EC, Manandhar-Sasaki P, Ban KF, Charles D, Braithwaite RS (2023).
Does the association between stimulant use and high risk sexual behavior vary by injection drug use, sexual minority status, or HIV infection status? A meta-analysis
AIDS and Behavior [Epub 2023 Feb 14]. doi: 10.1007/s10461-023-04012-4.

Bershteyn A, Richard E, Zhou Q, Khan MR, Scheidell JD, Manandhar-Sasaki P, Ban K, Crystal S, Gordon AJ, Justice AC, Bryant KJ, Braithwaite RS (2023).
Potential health benefits of integrated screening strategies for alcohol, tobacco, other substance use, depression, anxiety, and chronic pain among people living with HIV in the USA: A mathematical modelling study
Lancet HIV, 10 (2), e118-e125. doi: 10.1016/S2352-3018(22)00361-7.

Kim HY, Bershteyn A, McGillen JB, Braithwaite RS (2023).
How severe would prioritization-induced bottlenecks need to be offset the benefits from prioritizing COVID-19 vaccination to those most at risk in New York City?
BMC Public Health, 23 (1), 174. doi: 10.1186/s12889-022-14846-7. PMCID: PMC9876757.

Pitts RA, Ban K, Greene RE, Kapadia F, Braithwaite RS (2023).
Sustaining PrEP prescriptions at a safety-net hospital in New York City during COVID-19: Lessons learned
AIDS and Behavior [Epub 2023 Jan 7]. doi: 10.1007/s10461-023-03977-6. PMCID: PMC9825066.

Scheidell JD, Townsend T, Ban KF, Caniglia EC, Charles D, Edelman EJ, Marshall BDL, Gordon AJ, Justice AC, Braithwaite RS, Khan MR (2023).
Cessation of self-reported opioid use and impacts on co-occurring health conditions
Drug and Alcohol Dependence, 242, 109712. doi: 10.1016/j.drugalcdep.2022.109712.

Dr. Braithwaite's ResearchGate Profile